scispace - formally typeset
Search or ask a question
Journal ArticleDOI

Effects of 2 low-fat stanol ester–containing margarines on serum cholesterol concentrations as part of a low-fat diet in hypercholesterolemic subjects

01 Mar 1999-The American Journal of Clinical Nutrition (American Society for Nutrition)-Vol. 69, Iss: 3, pp 403-410
TL;DR: It is concluded that the low-fat, plant stanol ester-containing margarines are effective cholesterol-lowering products in hypercholesterolemic subjects when used as part of a low-Fat, low-cholesterol diet.
About: This article is published in The American Journal of Clinical Nutrition.The article was published on 1999-03-01 and is currently open access. It has received 240 citations till now. The article focuses on the topics: Stanol ester & Plant stanol ester.
Citations
More filters
Journal ArticleDOI
TL;DR: Plant sterol containing products reduced LDL concentrations but the reduction was related to individuals’ baseline LDL levels, food carrier, and frequency and time of intake, and the observed differences between trial results were unlikely to have been caused by chance.
Abstract: Background: Consumption of plant sterols has been reported to reduce low density lipoprotein (LDL) cholesterol concentrations by 5 to 15%. Factors that affect plant sterol efficacy are still to be determined. Objective: To more precisely quantify the effect of plant sterols on LDL cholesterol concentrations in humans and to look into factors that affect plant sterols efficacy. Design: Fifty nine eligible randomized clinical trials published from 1992 to 2006 were identified from five databases. Weighted mean effect sizes were calculated for net differences in LDL levels using a random effect model (RevMan 4.2). Results: Plant sterol containing products decreased LDL levels by 0.31 mmol/L (95% CI, -0.35 to -0.27, P= Keywords : meta-analysis; plant sterols; LDL cholesterol; intake frequency; single dose; food carrier (Published online: 18 August, 2008) Citation: Food & Nutrition Research 2008. DOI: 10.3402/fnr.v52i0.1811

323 citations


Additional excerpts

  • ...(1999a) (10) margarine stanol esters 2....

    [...]

  • ...(1999a) (10) parallel 8 37 high 5 50% males 41 Tx 46 Co B24....

    [...]

  • ...(1999b) (10) parallel 8 35 high 5 50% males 43 Tx 46 Co 25 29....

    [...]

  • ...(1999b) (10) margarine stanol esters 2....

    [...]

Journal ArticleDOI
TL;DR: Phytosterols have been used as blood cholesterol–lowering agents for the last half century and at the current level of usage, no adverse effects have been observed.

291 citations

Journal ArticleDOI
TL;DR: This review focuses first on present knowledge of the physiology of intestinal fat absorption, necessary to understand the ways to manipulate it in order to obtain the desired effects on dietary triglyceride and cholesterol disposition, and on potential therapeutic targets for inducing a controlled malabsorption of triglyceride.

281 citations

Journal ArticleDOI
TL;DR: The clinical and biochemical features of hereditary sitosterolemia, as well as its treatment, are reviewed, and the effects of cholestyramine treatment in 12Sitosterolemic subjects are summarized.

270 citations

References
More filters
Journal ArticleDOI
16 Jun 1993-JAMA
TL;DR: Dairy therapy remains the first line of treatment of high blood cholesterol, and drug therapy is reserved for patients who are considered to be at high risk for CHD, and the fundamental approach to treatment is comparable.
Abstract: THE SECOND report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II, or ATP II) presents the National Cholesterol Education Program's updated recommendations for cholesterol management. It is similar to the first in general outline, and the fundamental approach to treatment of high blood cholesterol is comparable. This report continues to identify low-density lipoproteins (LDL) as the primary target of cholesterol-lowering therapy. As in the first report, the second report emphasizes the role of the clinical approach in primary prevention of coronary heart disease (CHD). Dietary therapy remains the first line of treatment of high blood cholesterol, and drug therapy is reserved for patients who are considered to be at high risk for CHD. However, the second report contains new features that distinguish it from the first. These include the following: Increased emphasis on See also pp 3002 and 3009.

28,495 citations

Book
01 Jan 1993
TL;DR: In an ultrasonic alarm detector of the doppler detection type, the improvement comprising a second transmitter transducer disposed remote from the detector and driven from the master oscillator at the detector thereby extending the operating range of the detector to up to twice the range attainable without the second transmitter Transducer.
Abstract: SPSS for Windows: base system user's guide release 6.0 , SPSS for Windows: base system user's guide release 6.0 , مرکز فناوری اطلاعات و اطلاع رسانی کشاورزی

1,643 citations

Journal ArticleDOI
TL;DR: In this paper, the authors tested the tolerability and cholesterol-lowering effect of margarine containing sitostanol ester in a population with mild hypercholesterolemia.
Abstract: Background Dietary plant sterols, especially sitostanol, reduce serum cholesterol by inhibiting cholesterol absorption. Soluble sitostanol may be more effective than a less soluble preparation. We tested the tolerability and cholesterol-lowering effect of margarine containing sitostanol ester in a population with mild hypercholesterolemia. Methods We conducted a one-year, randomized, double-blind study in 153 randomly selected subjects with mild hypercholesterolemia. Fifty-one consumed margarine without sitostanol ester (the control group), and 102 consumed margarine containing sitostanol ester (1.8 or 2.6 g of sitostanol per day). Results The margarine containing sitostanol ester was well tolerated. The mean one-year reduction in serum cholesterol was 10.2 percent in the sitostanol group, as compared with an increase of 0.1 percent in the control group. The difference in the change in serum cholesterol concentration between the two groups was -24 mg per deciliter (95 percent confidence interval, -17 to -...

752 citations